Dcf Advisers, LLC Pfizer Inc Transaction History

Dcf Advisers, LLC

$177 Million
Q4 2024

A detailed history of Dcf Advisers, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Dcf Advisers, LLC holds 51,350 shares of PFE stock, worth $1.35 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

51,350

Previous 34,350 49.49%

Holding current value

$1.35 Million

Previous $994,000 37.02%

% of portfolio

0.77%

Previous 0.41%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$24.8 - $30.19 $421,600 - $513,230	17,000 Added 49.49%	51,350 $1.36 Million
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $24,930 - $28,251	-900 Reduced 2.55%	34,350 $994,000
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $404,160 - $473,600	16,000 Added 83.12%	35,250 $986,000
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $58,252 - $66,892	-2,250 Reduced 10.47%	19,250 $534,000
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $444,210 - $576,980	-17,000 Reduced 44.16%	21,500 $618,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $56,157 - $65,642	-1,750 Reduced 4.35%	38,500 $1.28 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $157,560 - $205,120	4,000 Added 11.03%	40,250 $1.64 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $476,932 - $565,492	-10,250 Reduced 22.04%	36,250 $1.9 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $846,375 - $1.05 Million	-18,500 Reduced 28.46%	46,500 $2.41 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $1.8 Million - $2.03 Million	50,000 Added 333.33%	65,000 $2.55 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $502,350 - $566,550	15,000 New	15,000 $543,000

Others Institutions Holding PFE

# of Institutions

3,354

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.

Account